key: cord-0849633-nwmepgq6 authors: Bayraktar, Nihayet; Turan, Hamdiye; Bayraktar, Mehmet; Ozturk, Ali; Erdoğdu, Hamza title: Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID‐19 date: 2021-08-30 journal: J Med Virol DOI: 10.1002/jmv.27294 sha: fcc13006af06c7aec2ca9245e41f763bf3520ea3 doc_id: 849633 cord_uid: nwmepgq6 In this study, we investigated the role and relationship between the cytokine profile and protective vitamin D by measuring their serum levels in COVID‐19 intensive care unit patients with severe illnesses. A total of 74 patients were included in our study. Patients were divided into two groups. Patients in the COVID‐19 group (n = 31) and individuals without a history of serious illness or infection were used as the control group (n = 43). The serum concentrations of interleukin‐1 (IL‐1), IL‐6, IL‐10, IL‐21, and tumor necrosis factor‐α (TNF‐α) were measured by enzyme‐linked immunosorbent assays. Levels of serum vitamin D were detected with Liquid chromatography–mass spectrometry methodologies. TNF‐α, IL‐1, IL‐6, IL‐10, IL‐21, and vitamin D levels were measured in all patients. The serum cytokine levels in the COVID‐19 patient group were significantly higher (151.59 ± 56.50, 140.37 ± 64.32, 249.02 ± 62.84, 129.04 ± 31.64, and 123.58 ± 24.49, respectively) than control groups. Serum vitamin D was also significantly low (6.82 ± 3.29) in patients in the COVID‐19 group than the controls (21.96 ± 5.39). Regarding the correlation of vitamin D with cytokine levels, it was significantly variable. Our study shows that COVID‐19 patients are associated with lower serum vitamin D and higher pro‐inflammatory cytokines associated with increased virus presence. Our data provide more evidence of the anti‐inflammatory effect of vitamin D on COVID‐19 patients and the protective effects of vitamin D on risk were demonstrated. Organization (WHO) COVID-19 dashboard. 2 On the same date, the Ministry of Health in Turkey announced a total of 5,514,373 confirmed cases and 50,450 death. 3 The SARS-CoV-2 virus is usually transmitted through droplets created by the infected person coughing, sneezing, or exhaling as these droplets are very heavy, they cannot remain suspended in the air and immediately fall to the ground or surfaces. Individuals can become infected if they inhale the virus while they are near someone infected with COVID-19 or if they touch their eyes, nose, or mouth after touching an infected surface. Most people who contract COVID-19 experience mild, moderate to severe symptoms, and some recover without the need for special treatment or hospitalization. The most common symptoms are fever, dry cough, tiredness, throat ache, loss of taste or sense of smell, headache, and diarrhea. 4, [5] [6] [7] Serious symptoms are difficulty breathing or shortness of breath, chest pain or pressure in the chest, and loss of speech or movement. Older adults and those with underlying comorbidities or chronic diseases are at higher risk for developing the severe disease. 4, 8 COVID-19 mainly affects the respiratory, cardiovascular, and gastrointestinal systems. 4 It was found that a significant proportion of deaths occurred more than 2 weeks after the onset of symptoms suspected of being caused by cytokine storms. 4, 9 The immune system is divided into two parts: innate and adaptive immunity which are activated shortly after microbial infections to provide protection against them. The activities of the cells of innate and adaptive immunity are coordinated by cytokines. 10 Emerging data reveal the activation of natural killer (NK) cells, innate immune effector cells, which not only contribute to the resolution of SARS-CoV-2 infection but also the cytokine storm found in acute respiratory disease syndromes (ARDS). 11, 12 Vitamin D is a group of fat-soluble steroids with a four-ringed cholesterol backbone. It is involved in calcium absorption, immune function, and protecting bone, muscle, and heart health. The most common vitamin D cholecalciferol (Vitamin D 3 ) and ergocalciferol (Vitamin D 2 ) are precursors of 1,25 (OH) 2D3 the active form of vitamin D. 13 Previous clinical studies have been shown that vitamin D regulates cytokine and immune in acute viral respiratory infections. [14] [15] [16] [17] Vitamin D increased the antiinflammatory phenotype while the pro-inflammatory cytokines induced an inflammatory phenotype. Similar studies have shown that vitamin D inhibits the production of pro-inflammatory cytokines (IL-6, tumor necrosis factor-α [TNF-α], IL-1, IL-21, IL-10) by macrophages and T cells. [17] [18] [19] [20] [21] Analyzing data during the COVID-19 outbreak suggests that vitamin D plays a role in reducing the development of pneumonia and improving case fatality rates. 17 Inflammatory cytokines include TNF-α, IL-1, and IL-6. IL-10 is an anti-inflammatory cytokine that downregulates the expression of Th1 cytokines, MHC class II antigens, and costimulatory molecules on macrophages. IL-21 is a cytokine that has potent regulatory effects on cells of the immune system, including NK cells and cytotoxic T cells that can destroy virally infected or cancerous cells. It has been associated with allergies, cancer, and viral infections. 22 Previous therapeutic strategies have demonstrated targeting cytokines or altering the cytokine response with or without the combination of antiviral agents can aid in the recovery from influenza. 13 There are no recent studies investigating vitamin D sta- The classification of severe cases in COVID-19 patients was made according to presence or absence of the following criteria: respiratory distress, tachypnea ≥30 beats/min; blood oxygen saturation (SpO 2 ) level ≤90%; arterial blood oxygen partial pressure/ oxygen concentration ≤300 mmHg; and evidence of bilateral diffuse pneumonia on chest X-ray or chest computed tomography (CT). 23 Case history or anamnesis, reverse-transcription polymerase chain reaction (RT-PCR) test results, and chest CT data of studied patients were obtained from the clinical records of our hospital. The statistical analysis was conducted using the Statistical Package for the Social Sciences for Windows, version 20.0 (SPSS Inc.) software program. The data were represented by averages ± standard deviations, numbers, and percentages. Categorical variables were compared using the χ 2 test. In the normally distributed constant data comparison, the Student t test was used, and in the non-normally distributed group, the Mann-Whitney U test was used. The Kruskal-Wallis test was used to compare more than two independent groups. A p < 0.05 value was accepted as the significance level. According to the gender and age of the participants, a total of 31 respectively. Compared with the control group, the levels of all cytokines were found to be significantly higher in the COVID-19 patient group. The results for the cytokines and vitamin D levels studied in the sera of patients and control groups are summarized in Table 1 . Serum vitamin D was also significantly low (6.82 ± 3.29) in patients with the COVID-19 group than in the control group (21.96 ± 5.39) ( Table 1) . As seen in Figure 1 , when the COVID-19 patient group was compared with the control group, serum IL-6 was the highest, followed by TNF-α, and then IL-1, IL-10, and IL-21, respectively. Vitamin D was found to be decreased compared to the control group ( Figure 1 ). (Table 2 ). Regarding correlations within tested cytokines, as shown in Table 2 , they were positive except IL-10 which had a negative correlation with IL-6 (−0.076, p > 0.05) and IL-21 (−0.021, p < 0.05). In this study, anti-inflammatory cytokines included IL-10 and pro-inflammatory cytokines included (TNF-α, IL-1, IL-6, and IL-21). We constructed serum cytokine profiles which included individual serum cytokines levels, ratios of anti-inflammatory to proinflammatory cytokines, sums of anti-inflammatory cytokines, combinations of sums of pro-inflammatory cytokines, and ratios of sums of anti-inflammatory cytokines to sums of pro-inflammatory cytokines (Table 2) . We plotted serum cytokine profiles as a function of serum vitamin D. Abbreviations: IL-1, interleukin-1; TNF-α, tumor necrosis factor-α. COVID-19 is an important viral respiratory human disease that resembles influenza in that it causes epidemics and pandemics with increased morbidity and mortality especially in the elderly and those with pre-existing medical conditions. It seems to spread more easily than the flu and causes more serious illnesses in some people. SARS-CoV-2 can infect both the lung epithelium and endothelial cells with the onset of infection. 26 The role of endothelial cell involvement in lung inflammation has increased pro-inflammatory cytokines production. 27,28 19, 20 In the definition of vitamin D status, International Organization for Migration committee members reported that the value of vitamin D 25(OH)D levels is >20 ng/m (>50 nmol) is considered sufficient but if it is <20 ng/ml (<50 nmol/L) it is deficient. 24, 45 According to the Endocrine Society vitamin D guidelines, the state of individuals with 25(OH)D < 20 ng/ml (<50 nmol/L) is deficient, 21-29 ng/ml (50-75 nmol/L) is insufficient, and levels >30 ng/ml (>75 nmol/L) is sufficient. 25, 46 In this study, the status of serum vitamin D level was deficient among COVID-19 patients whereas in controls was insufficient. The low serum vitamin level in our population may be due to increased melanin, malabsorption, obese children and adults, and individuals who practice abstinence from direct sunlight. 24 There are some limitations to our study. First, the low number of samples taken from COVID-19-infected patients. Second, we were unable to study cytokines in respiratory samples and to test other important recently discovered cytokines such as IL-25, IL-29, and IL-35 due to cost and insufficient financial support. Therefore, we suggest a multicenter study with a large number of samples to obtain more robust and beneficial results. So, such data will increase our horizon of knowledge of the subject. COVID-19 virus induces cytokine production. It induces proinflammatory responses, proliferates efficiently from the human respiratory tract, those infected with viruses increase pro-inflammatory cytokine and chemokine production within 24 h. Levels of all viruses tested were measured and high cytokines were found, especially IL-6, TNF-α levels were found to be significantly higher. Our data in Table 1 Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China World Health Organization Ministry of Health. COVID-19 Status Report Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome Understanding SARS-CoV-2: genetic diversity, transmission and cure in human It is time to address airborne transmission of COVID 19 Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis A comprehensive review of COVID-19 characteristics Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2 Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis The association between vitamin D status and infectious diseases of the respiratory system in infancy and childhood Vitamin D modulation of innate immune responses to respiratory viral infections The importance of vitamin D metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19 Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state Vitamin D measurement, the debates continue, new analytes have emerged, developments have variable outcomes Vitamin D(3) downregulates proinflammatory cytokine response to Mycobacterium tuberculosis through pattern recognition receptors while inducing protective cathelicidin production Vitamin D in inflammatory diseases Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses Republic of Turkey Ministry of Health. COVID-19 (SARS-CoV2 infection) guide. Adult patient treatment Vitamin D deficiency and its treatment in cystic fibrosis The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention SARS-CoV-2 infects endothelial cells in vivo and in vitro The cytokine storm of severe influenza and development of immunomodulatory therapy Cytokines induced during influenza virus infection Analysis of serum cytokines in patients with severe acute respiratory syndrome Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome Middle East respiratory syndrome coronavirus (MERS-CoV): infection, immunological response, and vaccine development MERS-CoV infection in humans is associated with a proinflammatory Th1 and Th17 cytokine profile TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties IL-17 family cytokines and the expanding diversity of effector T cell lineages IL-21 mediates suppressive effects via its induction of IL-10 The regulation of IL-10 production by immune cells IL-21 and T cell differentiation: consider the context Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses Interleukin-21: a new modulator of immunity, infection, and cancer Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors Cytokines and COVID-19: friends or foes? Toll-like receptor triggering of a vitamin d-mediated human antimicrobial response Vitamin D and the intracrinology of innate immunity Treatment of vitamin D deficiency in cystic fibrosis Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline Application of vitamin D and vitamin D analogs in acute myelogenous leukemia The role of IL-21 in immunity and cancer Immune modulatory effects of vitamin D on viral infections Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19 The authors declare that therer are no conflict of interests. The data that support the findings of this study are available from the corresponding author upon reasonable request.